FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
13.79 |
IU/g |
1.7 |
4.8 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45954 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
4.63 |
ml/min/g |
0.68 |
1.92 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44753 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
40.29 |
% |
4.67 |
13.21 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47112 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
0.33 |
IU/g |
0.05 |
0.17 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47292 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
11.64 |
ml/min/g |
0.67 |
2.02 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46688 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
4.42 |
ml/min/g |
0.44 |
1.39 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46236 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
5.18 |
ml/min/g |
0.87 |
2.76 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44748 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
9.27 |
ml/min/g |
0.6 |
1.88 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46905 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
57.45 |
% |
5.19 |
14.69 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46096 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
|
9.4 |
ml/min/g |
0.68 |
1.93 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46900 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
23.16 |
IU/g |
1.55 |
4.39 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48843 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
18.72 |
IU/g |
2.37 |
6.7 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45958 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.28 |
IU/g |
0.07 |
0.22 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47427 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.43 |
IU/g |
0.07 |
0.22 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47434 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
0.4 |
IU/g |
0.08 |
0.23 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47285 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
|
5.34 |
ml/min/g |
0.56 |
1.57 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46231 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
47.17 |
% |
2.87 |
9.06 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46101 |
461 |
FHH-Chr 5BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
20.16 |
IU/g |
1.41 |
4.45 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48847 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
43.09 |
% |
4.94 |
15.64 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47107 |
461 |
FHH-Chr 5BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
11.57 |
ml/min/g |
0.64 |
2.03 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46683 |
461 |